Gynecologic oncology care now available at Providence Cancer Institute

November 19, 2020 Providence Pulse Content Team

Patients now have access to an experienced, specialized team in gynecology oncology as part of Providence Cancer Institute. The new Gynecologic Oncology Program – led by Christopher Darus, M.D., MS, – can evaluate and treat gynecologic cancers, including ovarian, cervical, uterine, vaginal, fallopian and vulvar cancers, as well as precancerous conditions. 

The Providence Gynecologic Oncology Program provides specialized care for women with suspected or known gynecologic malignancies and complex precancerous conditions. Through the program, patients have access to advanced treatments, such as robotic surgery, immunotherapy, and the latest research and clinical trials. Patients also have the convenience of receiving all their care under one roof.

Our team of experts

We’re pleased to welcome Dr. Christopher Darus as medical director of the Gynecologic Oncology Program. He most recently served as attending physician and director of research, gynecologic oncology, Maine Medical Center.

Dr. Darus graduated from Wright State University School of Medicine in 2000 and completed his residency in obstetrics and gynecology at University of Colorado Health Sciences Center in 2004. Following his residency, he completed a fellowship in gynecologic oncology at the University of Virginia in 2007.

Additional providers will join the program in early 2021.

In addition to our gynecologic oncologists, members of the team include oncology nurses, radiation oncologists, gynecologic pathologists, genetic risk experts, oncology social workers, integrative medicine providers, nutrition specialists, clinical trials nurses, medical assistants and others.

Types of gynecologic cancers and conditions treated

  • Uterine/endometrial cancer
  • Ovarian/fallopian tube cancer
    • Primary peritoneal cancer
  • Cervical cancer
  • Uterine sarcomas
  • Vulvar cancer
  • Vaginal cancer
  • Gestational trophoblastic neoplasia
    • Choriocarcinoma
  • Complex pelvic masses
  • Women at familial risk of gynecologic cancers
  • Post-menopausal bleeding
  • Pre-invasive conditions
    • Endometrial hyperplasia/neoplasia
    • Cervical dysplasia
    • Vaginal dysplasia
    • Vulvar dysplasia

Treatments and services provided

  • Advanced radical abdominal, pelvic, vulvo-vaginal surgery, minimally invasive surgery, and robotic surgery and sentinel node mapping
  • Chemotherapy
  • Biological therapy, including immunotherapy, targeted therapy and endocrine therapy
  • Radiation oncology offered through the Providence Radiation Oncology Program
  • Genomic sequencing
  • Genetic risk assessment 
  • Oncology nutrition
  • Integrative therapies (naturopathic medicine, acupuncture, therapeutic massage)
  • Innovative therapies and clinical trials through the Earle A. Chiles Research Institute, a division of Providence Cancer Institute located within the Robert W. Franz Cancer Center
  • Long-term follow-up care

For more information


Article authored by:
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed), physician executive, Providence Cancer Institute; director, division of surgical oncology, radiation oncology and clinical programs

About the Author

The Pulse content team focuses on bringing you the latest in clinical news from our world-class medical providers and physician leaders.

More Content by Providence Pulse Content Team
Previous Article
Confidential support for Providence providers and their families
Confidential support for Providence providers and their families

Caring for patients, while also caring for ourselves, can be challenging.

Next Article
Registry launched to improve care for Black patients with MS
Registry launched to improve care for Black patients with MS

Providence Multiple Sclerosis Center, in partnership with leading African American neurologists across the ...